Illumina (ILMN) Optics for Genomics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Illumina (ILMN) Optics for Genomics

ILMN 119.70

-0.2%

12:34 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mopgcw	6/15/2005 3:17:54 AM
	of 276

Illumina to Present at Invitrogen Investor Meeting 9:59 PM ET June 14, 2005 Illumina, Inc. (NASDAQ:ILMN) announced today that Thomas Rosso, Director of Oligo Operations, will present an update of Illumina's strategic collaboration with Invitrogen at that company's 2005 Investor Meeting in Carlsbad, California. Mr. Rosso's presentation will be webcast live beginning on or about 8:30 a.m. Pacific Time (PT) on Thursday, June 16, 2005 and may be accessed on Invitrogen's website at www.invitrogen.com in the Investor Relations section of the site. The webcast will be archived and available for seven days following the presentation. Illumina (www.illumina.com) is developing next-generation tools that permit large-scale analysis of genetic variation and function. The Company's proprietary BeadArray(TM) technology -- now used in leading genome centers around the world -- provides the throughput, cost effectiveness and flexibility to enable researchers in the life sciences and pharmaceutical industries to perform the billions of tests necessary to extract medically valuable information from advances in genomics and proteomics. This information will help pave the way to personalized medicine.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next